Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,634 | 131 | 97.6% |
| Education | $51.44 | 2 | 1.9% |
| Debt forgiveness | $14.11 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $492.87 | 36 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $456.05 | 10 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $236.09 | 15 | $0 (2024) |
| Axsome Therapeutics, Inc. | $225.29 | 10 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $176.61 | 11 | $0 (2024) |
| Corium, LLC | $172.18 | 7 | $0 (2024) |
| ITI, Inc. | $108.16 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $105.26 | 4 | $0 (2024) |
| Neos Therapeutics, LP | $105.26 | 6 | $0 (2024) |
| Alkermes, Inc. | $90.53 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,077 | 101 | Supernus Pharmaceuticals, Inc. ($456.05) |
| 2023 | $532.49 | 31 | Otsuka America Pharmaceutical, Inc. ($211.97) |
| 2021 | $89.11 | 2 | ALK-Abello, Inc ($75.00) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Central Nervous System | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: CNS | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Central Nervous System | ||||||
| 10/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Neuropsychiatry | ||||||
| 09/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: ADHD | ||||||
| 08/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 29 | $4,968 | $1,017 |
| 2022 | 7 | 198 | 253 | $38,285 | $11,497 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 17 | $4,284 | $906.24 | 21.2% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 12 | 12 | $684.00 | $110.91 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 68 | $12,036 | $3,470 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 58 | $8,378 | $2,708 | 32.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $5,111 | $1,615 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,924 | $1,140 | 29.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 43 | 43 | $4,085 | $1,034 | 25.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $2,870 | $928.34 | 32.3% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 28 | 33 | $1,881 | $601.94 | 32.0% |
About Asa Mair
Asa Mair is a Speech-Language Pathologist healthcare provider based in Monroe, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2020. The National Provider Identifier (NPI) number assigned to this provider is 1306458062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Asa Mair has received a total of $2,699 in payments from pharmaceutical and medical device companies, with $2,077 received in 2024. These payments were reported across 134 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,634).
As a Medicare-enrolled provider, Mair has provided services to 226 Medicare beneficiaries, totaling 282 services with total Medicare billing of $12,514. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Speech-Language Pathologist
- Other Specialties Physician Assistant
- Location Monroe, NC
- Active Since 08/23/2020
- Last Updated 04/12/2023
- Taxonomy Code 235Z00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306458062
Products in Payments
- Qelbree (Drug) $456.05
- CAPLYTA (Drug) $344.25
- Auvelity (Drug) $225.29
- ABILIFY MAINTENA (Drug) $194.06
- Austedo XR (Drug) $176.61
- REXULTI (Drug) $149.82
- Azstarys (Drug) $138.02
- ABILIFY ASIMTUFII (Drug) $118.55
- Adzenys XR-ODT (Drug) $105.26
- SPRAVATO (Drug) $105.26
- ARISTADA (Drug) $90.53
- VRAYLAR (Drug) $86.68
- INGREZZA (Drug) $81.57
- QUVIVIQ (Drug) $81.42
- JORNAY PM (Drug) $59.48
- NUEDEXTA (Drug) $39.48
- FANAPT (Drug) $39.26
- AZSTARYS (Drug) $34.16
- TRINTELLIX (Drug) $30.69
- ABILIFY MYCITE (Drug) $29.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Speech-Language Pathologist Doctors in Monroe
Ruth Roberts, Macccslp, MACCCSLP
Speech-Language Pathologist
Charles Herbst
Speech-Language Pathologist
Yitzchok Schlafrig, Slp, SLP
Speech-Language Pathologist
Mrs. Audrey Malloy, Ma Ccc-Slp, MA CCC-SLP
Speech-Language Pathologist
Mrs. Toinette Laguerre, M.s., Ccc-Slp, M.S., CCC-SLP
Speech-Language Pathologist
Michelle Thompson, Ms Ccc-Slp, MS CCC-SLP
Speech-Language Pathologist